Published in J Clin Endocrinol Metab on August 01, 1977
The ophthalmopathy of Graves' disease. West J Med (1985) 1.39
Graves' ophthalmopathy. Can Med Assoc J (1981) 0.91
Long-term follow-up of ophthalmic Graves' disease. CMAJ (1987) 0.87
Ocular muscle surgery in Graves' disease. Trans Am Ophthalmol Soc (1978) 0.78
Identification and characterization of a new member of the TNF family that induces apoptosis. Immunity (1995) 10.59
Open access echocardiography in management of heart failure in the community. BMJ (1995) 7.83
Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science (1991) 5.99
Heritable fragile sites on human chromosomes I. Factors affecting expression in lymphocyte culture. Am J Hum Genet (1979) 5.18
Febrile seizures and generalized epilepsy associated with a mutation in the Na+-channel beta1 subunit gene SCN1B. Nat Genet (1998) 4.91
Fragile sites on human chromosomes: demonstration of their dependence on the type of tissue culture medium. Science (1977) 4.59
Heritable fragile sites on human chromosomes II. Distribution, phenotypic effects, and cytogenetics. Am J Hum Genet (1979) 4.10
Mutant GABA(A) receptor gamma2-subunit in childhood absence epilepsy and febrile seizures. Nat Genet (2001) 3.83
Safety of transesophageal echocardiography. A multicenter survey of 10,419 examinations. Circulation (1991) 3.70
Treatment guidelines for patients with hyperthyroidism and hypothyroidism. Standards of Care Committee, American Thyroid Association. JAMA (1995) 3.68
Dynamic mutations: a new class of mutations causing human disease. Cell (1992) 3.63
Value of the electrocardiogram in identifying heart failure due to left ventricular systolic dysfunction. BMJ (1996) 3.59
Brief report: fulminating fat embolism syndrome caused by paradoxical embolism through a patent foramen ovale. N Engl J Med (1993) 3.55
Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet (1985) 3.42
Cysteamine, methionine, and penicillamine in the treatment of paracetamol poisoning. Lancet (1976) 3.41
Regional strain and strain rate measurements by cardiac ultrasound: principles, implementation and limitations. Eur J Echocardiogr (2000) 3.36
Incidence and origin of "null" alleles in the (AC)n microsatellite markers. Am J Hum Genet (1993) 3.18
A missense mutation in the neuronal nicotinic acetylcholine receptor alpha 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat Genet (1995) 3.15
CD30 antigen, a marker for Hodgkin's lymphoma, is a receptor whose ligand defines an emerging family of cytokines with homology to TNF. Cell (1993) 2.73
Fc alpha/mu receptor mediates endocytosis of IgM-coated microbes. Nat Immunol (2000) 2.66
DNAM-1, a novel adhesion molecule involved in the cytolytic function of T lymphocytes. Immunity (1996) 2.56
Conference report: International Workshop on the fragile X and X-linked mental retardation. Am J Med Genet (1984) 2.49
Unnecessary x ray examinations. BMJ (1989) 2.37
Simple repeat DNA is not replicated simply. Nat Genet (1994) 2.37
X-linked mental retardation with macro-orchidism and the fragile site at Xq 27 or 28. Hum Genet (1979) 2.12
Ventricular septal defects. Two dimensional echocardiographic and morphological correlations. Br Heart J (1982) 2.11
Diagnosis of heart tumours by transoesophageal echocardiography: a multicentre study in 154 patients. European Cooperative Study Group. Eur Heart J (1993) 2.10
Assignment of anonymous DNA probes to specific intervals of human chromosomes 16 and X. Hum Genet (1989) 2.10
Prospective surveillance of sympathetic ophthalmia in the UK and Republic of Ireland. Br J Ophthalmol (2000) 2.10
Clinical investigation of a true color scanning laser ophthalmoscope. Arch Ophthalmol (2001) 2.07
Dynamic mutation: possible mechanisms and significance in human disease. Trends Biochem Sci (1997) 2.04
Neuronal sodium-channel alpha1-subunit mutations in generalized epilepsy with febrile seizures plus. Am J Hum Genet (2001) 2.01
Isolation and characterisation of (AC)n microsatellite genetic markers from human chromosome 16. Genomics (1992) 2.00
Non-invasive diagnosis of coronary artery disease by quantitative stress echocardiography: optimal diagnostic models using off-line tissue Doppler in the MYDISE study. Eur Heart J (2003) 1.99
Fragile X syndrome: diagnosis using highly polymorphic microsatellite markers. Am J Hum Genet (1991) 1.95
Fragile X syndrome without CCG amplification has an FMR1 deletion. Nat Genet (1992) 1.91
Heritable fragile sites on human chromosomes. V. A new class of fragile site requiring BrdU for expression. Am J Hum Genet (1980) 1.88
bcl-w, a novel member of the bcl-2 family, promotes cell survival. Oncogene (1996) 1.87
Muc13, a novel human cell surface mucin expressed by epithelial and hemopoietic cells. J Biol Chem (2001) 1.86
Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat Genet (1995) 1.86
Myeloid DAP12-associating lectin (MDL)-1 is a cell surface receptor involved in the activation of myeloid cells. Proc Natl Acad Sci U S A (1999) 1.86
LAIR-1, a novel inhibitory receptor expressed on human mononuclear leukocytes. Immunity (1997) 1.85
Policy for prevention of Asian rickets in Britain: a preliminary assessment of the Glasgow rickets campaign. Br Med J (Clin Res Ed) (1981) 1.83
A comparative evaluation of digital imaging, retinal photography and optometrist examination in screening for diabetic retinopathy. Diabet Med (2003) 1.72
Explanation for exclusive maternal origin for congenital form of myotonic dystrophy. Lancet (1993) 1.72
Fragile X syndrome: genetic localisation by linkage mapping of two microsatellite repeats FRAXAC1 and FRAXAC2 which immediately flank the fragile site. J Med Genet (1991) 1.71
Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol (1999) 1.70
Mapping the short arm of human chromosome 16. Genomics (1989) 1.69
Episcleritis and scleritis. A study of their clinical manifestations and association with rheumatoid arthritis. Br J Ophthalmol (1976) 1.69
Inhibition of phagocytosis by high molecular weight hyaluronate. Immunology (1980) 1.67
Idebenone treatment in Friedreich's ataxia: neurological, cardiac, and biochemical monitoring. Neurology (2003) 1.67
The detection of fat embolism by transoesophageal echocardiography during reamed intramedullary nailing. A study of 24 patients with femoral and tibial fractures. J Bone Joint Surg Br (1993) 1.66
Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys (1990) 1.65
Anatomical basis of cross sectional echocardiography. Br Heart J (1983) 1.63
Down's syndrome in South Australia. Med J Aust (1979) 1.63
The CD39 lymphoid cell activation antigen. Molecular cloning and structural characterization. J Immunol (1994) 1.63
Diagnosis of atrial situs by transesophageal echocardiography. J Am Coll Cardiol (1990) 1.62
Gene structure alternative splicing, and chromosomal localization of pro-apoptotic Bcl-2 relative Bim. Mamm Genome (2001) 1.62
Identification of the gene FMR2, associated with FRAXE mental retardation. Nat Genet (1996) 1.61
Molecular and biological characterization of human 4-1BB and its ligand. Eur J Immunol (1994) 1.59
Orientation and directed migration of cultured corneal epithelial cells in small electric fields are serum dependent. J Cell Sci (1996) 1.58
Prevention of rickets in Asian children: assessment of the Glasgow campaign. Br Med J (Clin Res Ed) (1985) 1.58
Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med (1996) 1.57
Partial and complete trisomy 9: delineation of a trisomy 9 syndrome. Hum Genet (1976) 1.56
Transesophageal echocardiographic monitoring of interventional cardiac catheterization in children. J Am Coll Cardiol (1991) 1.56
Identification of a human HECT family protein with homology to the Drosophila tumor suppressor gene hyperplastic discs. Oncogene (1998) 1.56
Fine mapping of gene probes and anonymous DNA fragments to the long arm of chromosome 16. Genomics (1988) 1.55
Human chromosomal fragile site FRA16B is an amplified AT-rich minisatellite repeat. Cell (1997) 1.55
Heritable fragile sites on human chromosomes. VII. Children homozygous for the BrdU-requiring fra(10)(q25) are phenotypically normal. Am J Hum Genet (1981) 1.55
Location and activity of ulcerative and Crohn's colitis by indium 111 leukocyte scan. A prospective comparison study. Gastroenterology (1983) 1.54
The corneoscleral limbus in human corneal epithelial wound healing. Am J Ophthalmol (1990) 1.54
Two novel mucin genes down-regulated in colorectal cancer identified by differential display. Cancer Res (1999) 1.52
Molecular characterization of murine and human OX40/OX40 ligand systems: identification of a human OX40 ligand as the HTLV-1-regulated protein gp34. EMBO J (1994) 1.52
Urokinase in the treatment of vitreous haemorrhage. Lancet (1972) 1.51
Heritable fragile sites on human chromosomes. III. Detection of fra(X)(q27) in males with X-linked mental retardation and in their female relatives. Hum Genet (1979) 1.51
Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science (1994) 1.51
Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med (1991) 1.50
At least two different regions are involved in allelic imbalance on chromosome arm 16q in breast cancer. Genes Chromosomes Cancer (1994) 1.50
High frame rate myocardial integrated backscatter. Does this change our understanding of this acoustic parameter? Eur J Echocardiogr (2000) 1.49
The fragile X chromosome. Int Rev Cytol (1983) 1.49
Report of the committee on cytogenetic markers. Cytogenet Cell Genet (1989) 1.48
Ultrasonography and indium 111 white blood cell scanning for the detection of intraabdominal abscesses. Radiology (1981) 1.48
Colour Doppler velocity imaging of the myocardium. Ultrasound Med Biol (1992) 1.48
An image-processing strategy for the segmentation and quantification of microaneurysms in fluorescein angiograms of the ocular fundus. Comput Biomed Res (1996) 1.47
The value of Doppler color flow mapping in determining pulmonary blood supply in infants with pulmonary atresia with ventricular septal defect. J Am Coll Cardiol (1989) 1.47
Hyperthyroidism with low radioiodine uptake after head and neck irradiation for Hodgkin's disease. J Nucl Med (1989) 1.47
Ventilation and acid-base changes in deep coma due to barbiturate or tricyclic antidepressant poisoning. Clin Toxicol (1977) 1.47
Hippocampal neurons are damaged by caffeine-augmented electroshock seizures. Biol Psychiatry (1996) 1.46
Quantitative image analysis of macular drusen from fundus photographs and scanning laser ophthalmoscope images. Eye (Lond) (1995) 1.45
Electron microscopic evidence against apoptosis as the mechanism of neuronal death in global ischemia. J Neurosci (1999) 1.45
Assessing diagnosis in heart failure: which features are any use? QJM (1997) 1.45
Transesophageal echocardiography. J Am Soc Echocardiogr (1990) 1.44
Cloning, chromosomal mapping and characterization of the human metal-regulatory transcription factor MTF-1. Nucleic Acids Res (1994) 1.42
Analysis of reproducibility of reference lumen quantitation with intravascular ultrasound in stented coronary arteries. Cathet Cardiovasc Diagn (1997) 1.42
Dinucleotide repeat polymorphisms at the D16S164, D16S168 and D16S186 loci at 16q21-q22.1. Nucleic Acids Res (1991) 1.42
Bovine latent transforming growth factor beta 1-binding protein 2: molecular cloning, identification of tissue isoforms, and immunolocalization to elastin-associated microfibrils. Mol Cell Biol (1995) 1.42
HPP1: a transmembrane protein-encoding gene commonly methylated in colorectal polyps and cancers. Proc Natl Acad Sci U S A (2001) 1.41
Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis? Eye (Lond) (1997) 1.41
Evaluation of 111In leukocyte whole body scanning. AJR Am J Roentgenol (1979) 1.41
Cell subpopulations in failed human corneal grafts. Br J Ophthalmol (1999) 1.41